With FDA approval, Jazz and Roche's combo sets new bar in first-line small cell lung cancer
3rd October 2025 Uncategorised 0The FDA has approved Jazz Pharmaceuticals’ Zepzelca, used in combination with Roche’s Tecentriq, as a first-line maintenance treatment in extensive-stage small cell lung cancer
More: With FDA approval, Jazz and Roche's combo sets new bar in first-line small cell lung cancer
Source: fierce